White Paper: Recruiting and retaining talent who make life-saving medicine; State of Pharmaceutical Manufacturing Workforce in Indiana

BioCrossroads and Ascend Indiana release new white paper on pharmaceutical manufacturing and talent

Indiana is experiencing significant statewide growth in pharmaceutical manufacturing (Indiana ranks #1 in the nation for pharmaceutical exports) but this boom in high-quality, high-paying jobs is challenged by a shortage of qualified workers. BioCrossroads, in partnership with Ascend Indiana, convened pharmaceutical manufacturers, postsecondary education institutions, and state officials to explore how to develop a robust […]

Indiana leads the U.S. in pharmaceutical exports

BioCrossroads announce Indiana leads U.S. in pharmaceutical exports

INDIANAPOLIS (March 2, 2023) — Indiana leads the United States in pharmaceutical exports, according to new data from the Indiana Business Research Center at the Indiana University Kelley School of Business. Life sciences exports have always been a strong area for the state. Indiana has been one of the top three states in exports for […]

BioCrossroads President and CEO Patty Martin to step down

Patty Martin, president and CEO of BioCrossroads to step down.

INDIANAPOLIS (Feb. 14, 2023) —BioCrossroads announced today that Patty Martin, president and CEO, has decided to step down from the organization. Martin, who is an ardent and passionate catalyst and connector for the life sciences in Indiana, will continue her engagement with the life sciences industry in the private sector. “Patty’s energy and passion have […]

IBJ: Indiana Life Sciences Companies Raise Record $620M in 2022

Indiana life sciences sees record venture capital investment in 2022

A recent article in the Indianapolis Business Journal by reporter John Russell, shows that Indiana’s healthcare and life sciences sector, often hailed as a key driver of the state’s economy, landed a record $619.8 million in venture funding last year, a hefty increase over the previous record, set a year earlier. Data provided by CICP’s […]

New report tracks 20 years of BioCrossroads and life sciences industry’s success

BioCrossroads and the Indiana Life Sciences Ecosystem report

INDIANAPOLIS (Oct. 6, 2022) – Today, BioCrossroads released a new report from TEConomy that follows the impact of BioCrossroads and Indiana’s life sciences sector over the last two decades — BioCrossroads and the Indiana Life Sciences Ecosystem: Tracking Two Decades of Progress and Charting a Path for Sustained Success. The study highlights statistics that include […]

BioCrossroads Honors Life Sciences Innovators in Indiana

In an effort to recognize and honor some of the people leading the way and making significant contributions to the life sciences sector, our initiative BioCrossroads created the August M. Watanabe Life Sciences Champion of the Year Award to shine a light on innovation and growth in the state and recognize those whose impactful contributions have […]

Nora Doherty recognized as 2022 Watanabe Life Sciences Champion for strategic and meaningful impact on Indiana’s life sciences industry

Nora Doherty receives the August M. Watanabe Life Sciences Champion of the Year award

INDIANAPOLIS (Sept. 22, 2022) — BioCrossroads’ Board of Directors today named former executive vice president of strategy of BioCrossroads and managing director of the Indiana Seed Funds, Nora Doherty, as the recipient of the 2022 August M. Watanabe Life Sciences Champion of the Year Award. The prestigious honor, named in tribute to BioCrossroads’ late Chairman August […]

BioCrossroads announces 23 PAIR (Promising Achievers in Innovation and Research) winners

BioCrossroads 23 PAIR awards event

INDIANAPOLIS (August 24, 2022) — BioCrossroads today announced the winners of its inaugural 23 PAIR (Promising Achievers in Innovation and Research), a new recognition program that celebrates and promotes the state’s next generation of life sciences leaders. Award winners have exhibited significant industry or academic impact and success and are in the early stages of […]